RESP® for Asthma
Objectively measure wheeze and cough in asthma patients
As clinicians and drug developers look for asthma monitoring devices to strengthen disease surveillance and insight into treatment response, continuous cough and wheeze monitoring offers a promising approach. Wheezing, a hallmark symptom of asthma and an indication of airway obstruction is typically observed only subjectively by patients or clinicians via auscultation. Cough is also a prevalent, burdensome symptom in asthma — especially in cough variant asthma — and a common early sign of an attack.3
The RESP® Biosensor: Technology Overview
- Clinically validated accuracy, with equivalent performance to Littman 3200 electronic stethoscope¹
- Passive collection of lung sounds such as cough and wheeze to offer objective data on respiratory status passively and remotely
- Patient-friendly form factor: wireless and discreet without interfering with daily life
1. M. Glass, et al. Results of Clinical Performance Testing of a Novel Wearable e-Stethoscope in Patients with Chronic Lung Diseases [abstract]. Am J Respir Crit Care Med
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Wearable biosensor passively and continuously collects lung sounds and physiological data
RESP® Cloud
Captured data are securely and wirelessly transferred to HIPAA-compliant cloud for overread
Patient Reports
Once overread is complete, client receives detailed patient reports
Initial results from the study which took place at Ann & Lurie Children’s Hospital in Chicago showed positive feedback from patients and families as well as strong accuracy in detecting wheeze compared to physician auscultation.
TESTIMONIAL VIDEO
Hear from Sadia Benzaquen, MD, Director of Pulmonary & Critical Care at Einstein Philadelphia Hospital
Interested in a Research Collaboration?
We’re seeking clinical and academic collaborators to explore how wearable respiratory technologies can improve patient outcomes. Partners may be eligible for in-kind support.
For Healthcare
Improve management of adult and pediatric asthma with real-time monitoring of cough and wheeze
For Life Sciences
Gain greater, objective insight into subject treatment response in clinical trials for asthma
Track Patient Progress Objectively and Remotely
Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.
Publications
Explore our peer reviewed performance testing, studies and publications
Is the RESP® Biosensor reimbursable?
The RESP® Biosensor is reimbursable under RPM and RTM codes.
Is the RESP® Biosensor designed for continuous long-term monitoring?
Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day.
Which care settings is the RESP® Biosensor intended for?
The RESP® Biosensor is designed to be used across multiple care settings, including clinical trials, in-patient, transitional care, post-acute discharge, outpatient, and hospital at home.
Let’s Connect
Explore using the RESP® Biosensor in your study or practice
References
- Wang, Z., Li, Y., Gao, Y., Fu, Y., Lin, J., Lei, X., Zheng, J., & Jiang, M. (2023). Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respiratory research, 24(1), 169. https://doi.org/10.1186/s12931-023-02475-6
- Asthma and Allergy Foundation of America. Asthma Facts and Figures [Internet] Available at https://aafa.org/asthma/asthma-facts/
- NHS. Asthma Attacks [Internet]. https://www.nhs.uk/conditions/asthma/asthma-attack/